Fenimore Asset Management Trust’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Fenimore Asset Management Trust’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$231K	Buy	+1,369	New	+$220K	0.01%	98

Other funds holding LUMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fenimore Asset Management Trust's LUMO Position: Q3 2013 in Review

Fenimore Asset Management Trust opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2013: 1,369 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #98 among its holdings.

71 funds tracked by Wall St. Rank hold LUMO as of Q3 2013.

Fenimore Asset Management Trust held 1,369 shares of Lumos Pharma, Inc. Common Stock worth $231K as of Q3 2013.
Lumos Pharma, Inc. Common Stock was a new Fenimore Asset Management Trust position in Q3 2013.
Lumos Pharma, Inc. Common Stock made up 0.01% of Fenimore Asset Management Trust's portfolio in Q3 2013, its #98 holding.
71 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2013.

Based on Fenimore Asset Management Trust's 13F filing for Q3 2013, filed 10 Oct 2013.